Forbes Medi-Tech Inc. (FMTI) news stock charts
Forbes Medi-Tech Inc. (FMTI) Investment Summary:
We are a life sciences company dedicated to the research, development and commercialization of innovative products for the prevention and treatment of cardiovascular disease. Our vision is to develop and market products along a treatment continuum that consumers, healthcare professionals and specialized cardiovascular disease research and healthcare institutions will identify, recommend and seek. Our business strategy is to develop and commercialize proprietary compounds to address the unmet needs of patients within the cardiovascular disease market. Cardiovascular Disease The cardiovascular disease market continues to be one of the largest, with increasing prevalence in the developed and developing worlds. Patients are now living longer with the disease, which hosts a plethora of risk factors and interdependent manifestations. As a result, long-term management, and complexity and diversity in approach, are required. ... More..."http://secfilings.nasdaq.com/edgar_conv_html%2f2006%2f04%2f04%2f0001176256-06-000176.html#FIS_BUSINESS"www.forbesmedi.com
Founded in 1985
FORBES MEDI-TECH INC (FMTI:Pink OTC Markets Inc)
LAST $0.16 USD
CHANGE TODAY +0.004 2.65%
VOLUME 687.0
As of 10:18 AM 03/12/10 All times are local (Market data is delayed by at least 15 minutes).
Snapshot of FORBES MEDI-TECH INC (FMTI)
|
OPEN
$0.16
|
PREVIOUS CLOSE
$0.15
|
|
|
DAY HIGH
$0.16
|
DAY LOW
$0.16
|
|
|
52 WEEK HIGH
10/20/09 - $0.87
|
52 WEEK LOW
03/13/09 - $0.09
|
|
|
MARKET CAP
770.3K
|
AVERAGE VOLUME 10 D
18.4K
|
|
|
EPS TTM
--
|
SHARES OUTSTANDING
5.0M
|
|
|
FMTI Does Not Pay Dividends
|
P/E TTM
--
|
|
| K = Thousands M = Millions B = Billions | ||
Key developments for FORBES MEDI-TECH INC (FMTI)
Forbes Medi To Be Delisted From NASDAQ On February 18
02/17/2010
Forbes Medi Tech Inc. announced that it received notification on February 16, 2010 that a NASDAQ Listing Qualifications Panel has determined to delist the Company's securities from The NASDAQ Stock Market, effective with the open of business on February 18, 2010. The delisting is the result of the Company's failure to meet the $1.00 per share minimum bid price requirement. The Company has been advised by Pink OTC Markets Inc, that its securities are immediately eligible for quotation effective with the open of business on February 18, 2010. The Company's common stock may, in the future, also be quoted on the Over-the-Counter Bulletin Board (OTCBB), provided that a market maker in the Company's common stock files the appropriate application with, and such application is cleared by, FINRA (Financial Industry Regulatory Authority).
Forbes Medi Tech To Appeal Delisting Notice From NASDAQ
01/15/2010
Forbes Medi Tech Inc. said that it will appeal a delisting notice from the NASDAQ stock market. The firm said on January 14 that it is preparing a plan to regain compliance. Forbes Medi-Tech added that if its appeal is unsuccessful, the company will apply to have its stock trade on the over-the-counter market.
Forbes Medi Tech Receives Letter From NASDAQ
01/8/2010
Forbes Medi Tech Inc. announced that it has received a NASDAQ Staff Deficiency Letter indicating that it does not meet The NASDAQ Capital Market initial listing standard set forth in Listing Rule 5505 and unless the Company requests an appeal of the Staff's determination, the Company's common shares will be suspended at the opening of business on January 15, 2010, and a Form 25-NSE will be filed with the Securities and Exchange Commission which will remove the Company's common shares from listing and registration on The NASDAQ Stock Market. The Company may appeal Staff's determination to a Hearings Panel (Panel), pursuant to the procedures set forth in the NASDAQ Listing Rule 5800 Series, by providing notice of the appeal to NASDAQ by January 13, 2010. The Company will be required to provide a plan to regain compliance to the Panel. A hearing request would stay the suspension of the Company's securities and the filing of the Form 25-NSE pending the Panel's decision. The Company is considering its options for appeal and will announce if such an appeal is filed. If the Company does not appeal Staff's determination to the Panel, the Company intends to make application to have the Company's securities eligible to trade on the OTC Bulletin Board.
Forbes Medi-Tech Inc. financial resources
FMTI Competitors
| Company | Last | Change |
| Archer-Daniels-Midland Co | $29.19 USD | -0.25 |
| Bayer AG | €51.73 EUR | -0.31 |
| Mead Johnson Nutrition Co | $51.90 USD | +0.19 |
| Raisio PLC | €2.79 EUR | -0.02 |
| Unilever NV | €22.57 EUR | -0.045 |
| Market data is delayed at least 15 minutes. | ||
Industry Analysis
| Valuation | FMTI | Industry Range |
| Price/Earnings | -- | Not Meaningful |
| Price/Sales | -- | Not Meaningful |
| Price/Book | -- | Not Meaningful |
| Price/Cash Flow | -- | Not Meaningful |
| TEV/Sales | -- | Not Meaningful |
|
FMTI |
||
|
FMTI transactions
| Type Date |
Target | |
| No transactions in the last 6 months. | ||
More Recent Financial News About Forbes Medi-Tech Inc.
Forbes Medi-Tech Provides Update on TSX Listing
2010-01-26 04:42:13
Quote: Press ReleaseSource: Forbes Medi-Tech Inc.On Wednesday August 12, 2009, 9:00 am EDTVANCOUVER, BRITISH COLUMBIA--(Marketwire - 08/12/09) - Forbes Medi-Tech Inc. (TSX: - )(NASDAQ: - Forbes Medi-Tech Inc. (TSX: - )(NASDAQ: - ) is a life sciences company focused on evidence-based nutritional solutions. A leader in nutraceutical technology, Forbes is a provider of value-added products and cholesterol-lowering ingredients for use in functional foods and dietary supplements. Forbes successfully develop...Read article
Forbes Medi-Tech Provides Update on Stock Exchange Listings
2010-01-26 04:42:13
Quote: Press ReleaseSource: Forbes Medi-Tech Inc.On Wednesday July 15, 2009, 4:30 pm EDTVANCOUVER, BRITISH COLUMBIA--(Marketwire - 07/15/09) - Forbes Medi-Tech Inc. (TSX: - )(NASDAQ: - Forbes Medi-Tech Inc. (TSX: - )(NASDAQ: - ) is a life sciences company focused on evidence-based nutritional solutions. A leader in nutraceutical technology, Forbes is a provider of value-added products and cholesterol-lowering ingredients for use in functional foods and dietary supplements. Forbes successfully developed...Read article
Forbes Medi-Tech Announces Pharmavite Contract Renewal
2010-01-26 04:42:13
Quote: Press ReleaseSource: Forbes Medi-Tech Inc.On Wednesday June 10, 2009, 4:30 pm EDTVANCOUVER, BRITISH COLUMBIA--(Marketwire - June 10, 2009) - Forbes Medi-Tech Inc. (TSX: -NASDAQ: - CholestOff(TM) and CholestOff(TM) Complete(TM) are available in 60-count and 120-count caplet bottles. For more information on CholestOff(TM) products, visit . For more information on Reducol, visit For more than 30 years, Pharmavite has earned and maintained the trust of pharmacists, consumers, and retailers by manufa...Read article
Forbes Medi-Tech Cholesterol Lowering Ingredient Reducol(TM) Receives New Health Claim in the European Union
2010-01-26 04:42:12
Quote: Press ReleaseSource: Forbes Medi-Tech Inc.On Monday October 26, 2009, 7:30 pm EDTVANCOUVER, BRITISH COLUMBIA--(Marketwire - 10/26/09) - Forbes Medi-Tech Inc. (NASDAQ: - Forbes Medi-Tech Inc. (NASDAQ: - ) is a life sciences company focused on evidence-based nutritional solutions. A leader in nutraceutical technology, Forbes is a provider of value-added products and cholesterol-lowering ingredients for use in functional foods and dietary supplements. Forbes successfully developed and commercialize...Read article
Forbes Medi-Tech Announces Financial Results for Second Quarter Ended June 30, 2009
2010-01-26 04:42:12
Quote: Read article
Forbes Medi-Tech Announces the Launch of Del Monte Heart Smart Pineapple Juice Containing Reducol(TM) in the Philippines
2010-01-26 04:42:11
Quote: Press ReleaseSource: Forbes Medi-Tech Inc.On Monday December 7, 2009, 8:30 am ESTVANCOUVER, BRITISH COLUMBIA--(Marketwire - 12/07/09) - Forbes Medi-Tech Inc. (NASDAQ: - Reducol(TM) has been incorporated into a variety of foods - including yoghurts, yoghurt drinks, processed cheese, milk drinks and spreads - offering consumers a variety of dietary choices to help lower their LDL cholesterol levels. Additional information on Reducol(TM) may be found at: Forbes Medi-Tech Inc. (NASDAQ: - ) is a life...Read article
Forbes Medi-Tech Announces Financial Results for Third Quarter Ended September 30, 2009
2010-01-26 04:42:11
Quote: Read article
Forbes Medi-Tech Appeals NASDAQ Listing Suspension
2010-01-26 04:42:10
Quote: Press ReleaseSource: Forbes Medi-Tech Inc.On Thursday January 14, 2010, 9:00 am ESTVANCOUVER, BRITISH COLUMBIA--(Marketwire - 01/14/10) - Forbes Medi-Tech Inc. (NASDAQ: - Forbes Medi-Tech Inc. is a life sciences company focused on evidence-based nutritional solutions. A leader in nutraceutical technology, Forbes is a provider of value-added products and cholesterol-lowering ingredients for use in functional foods and dietary supplements. Forbes successfully developed and commercialized its Reduc...Read article
Forbes Medi-Tech Provides Update on NASDAQ Listing
2010-01-26 04:42:10
Quote: Press ReleaseSource: Forbes Medi-Tech Inc.On Friday January 8, 2010, 9:00 am ESTVANCOUVER, BRITISH COLUMBIA--(Marketwire - 01/08/10) - Forbes Medi-Tech Inc. (NASDAQ: - Forbes Medi-Tech Inc. is a life sciences company focused on evidence-based nutritional solutions. A leader in nutraceutical technology, Forbes is a provider of value-added products and cholesterol-lowering ingredients for use in functional foods and dietary supplements. Forbes successfully developed and commercialized its Reducol(...Read article
Forbes Medi-Tech Appeals NASDAQ Listing Suspension
2010-01-15 03:36:40
Quote: Press ReleaseSource: Forbes Medi-Tech Inc.On Thursday January 14, 2010, 9:00 am ESTVANCOUVER, BRITISH COLUMBIA--(Marketwire - 01/14/10) - Forbes Medi-Tech Inc. (NASDAQ: - Forbes Medi-Tech Inc. is a life sciences company focused on evidence-based nutritional solutions. A leader in nutraceutical technology, Forbes is a provider of value-added products and cholesterol-lowering ingredients for use in functional foods and dietary supplements. Forbes successfully developed and commercialized its Reduc...Read article
Forbes Medi-Tech Provides Update on NASDAQ Listing
2010-01-11 03:22:44
Quote: Press ReleaseSource: Forbes Medi-Tech Inc.On Friday January 8, 2010, 9:00 am ESTVANCOUVER, BRITISH COLUMBIA--(Marketwire - 01/08/10) - Forbes Medi-Tech Inc. (NASDAQ: - Forbes Medi-Tech Inc. is a life sciences company focused on evidence-based nutritional solutions. A leader in nutraceutical technology, Forbes is a provider of value-added products and cholesterol-lowering ingredients for use in functional foods and dietary supplements. Forbes successfully developed and commercialized its Reducol(...Read article
Forbes Medi-Tech Announces the Launch of Del Monte Heart Smart Pineapple Juice Containing Reducol(TM) in the Philippines
2009-12-08 04:03:08
Quote: Additional information on Reducol(TM) may be found at: Forbes Medi-Tech Inc. (NASDAQ: - ) is a life sciences company focused on evidence-based nutritional solutions. A leader in nutraceutical technology, Forbes is a provider of value-added products and cholesterol-lowering ingredients for use in functional foods and dietary supplements. Forbes successfully developed and commercialized its Reducol(TM) plant sterol blend, which has undergone clinical trials in various matrices and has been shown t...Read article
Forbes Medi-Tech Announces Financial Results for First Quarter Ended March 31, 2009
2009-11-30 05:16:29
Quote: Read article
Forbes Medi-Tech Announces Pharmavite Contract Renewal
2009-11-30 05:16:27
Quote: For more information please visit Forbes Medi-Tech Inc. (TSX: -NASDAQ: - Forbes Medi-Tech ("Forbes" or the "Company") has relied solely on Pharmavite LLC for the information about Pharmavite(TM), Nature Made®, CholestOff(TM) and CholestOff(TM) Complete(TM) provided in this News Release and the Company disclaims any liability with respect to such information. Forbes disclaims responsibility or liability for information contained in any linked or referenced website, and such links and referenc...Read article
Forbes Medi-Tech Regains Compliance with "Stockholders' Equity" Listing Requirement on Nasdaq Capital Market
2009-11-30 05:16:27
Quote: If the Company does not regain compliance by such date, its securities will be subject to delisting.About Forbes Medi-TechFMINews;FMTINews) is a life sciences company focused on evidence-based nutritional solutions. A leader in nutraceutical technology, Forbes is a provider of value-added products and cholesterol-lowering ingredients for use in functional foods and dietary supplements. Forbes successfully developed and commercialized its Reducol(TM) plant sterol blend, which has undergone clinic...Read article
Forbes Medi-Tech Provides Update on Stock Exchange Listings
2009-11-30 05:16:26
Quote: Forbes Medi-Tech Inc. (TSX: - )(NASDAQ: - ) is a life sciences company focused on evidence-based nutritional solutions. A leader in nutraceutical technology, Forbes is a provider of value-added products and cholesterol-lowering ingredients for use in functional foods and dietary supplements. Forbes successfully developed and commercialized its Reducol(TM) plant sterol blend, which has undergone clinical trials in various matrices and has been shown to lower "LDL" cholesterol levels safely and na...Read article
Forbes Medi-Tech Announces Financial Results for Second Quarter Ended June 30, 2009
2009-11-30 05:16:25
Quote: Read article
Forbes Medi-Tech Provides Update on TSX Listing
2009-11-30 05:16:25
Quote: Forbes Medi-Tech Inc. (TSX: - )(NASDAQ: - ) is a life sciences company focused on evidence-based nutritional solutions. A leader in nutraceutical technology, Forbes is a provider of value-added products and cholesterol-lowering ingredients for use in functional foods and dietary supplements. Forbes successfully developed and commercialized its Reducol(TM) plant sterol blend, which has undergone clinical trials in various matrices and has been shown to lower "LDL" cholesterol levels safely and na...Read article
Forbes Medi-Tech Announces Financial Results for Third Quarter Ended September 30, 2009
2009-11-30 05:16:24
Quote: Read article
Forbes Medi-Tech Cholesterol Lowering Ingredient Reducol(TM) Receives New Health Claim in the European Union
2009-11-30 05:16:24
Quote: Forbes Medi-Tech Inc. (NASDAQ: - ) is a life sciences company focused on evidence-based nutritional solutions. A leader in nutraceutical technology, Forbes is a provider of value-added products and cholesterol-lowering ingredients for use in functional foods and dietary supplements. Forbes successfully developed and commercialized its Reducol(TM) plant sterol blend, which has undergone clinical trials in various matrices and has been shown to lower "LDL" cholesterol levels safely and naturally. ...Read article
Would you like to leave a comment about Forbes Medi-Tech Inc. FMTI
Find out what social network information about Forbes Medi-Tech Inc. are available on RealpenniesWorst 5 - Click here to find out what stocks have been voted down by our visitors and users
Besides Forbes Medi-Tech Inc.'s Stock there is more great penny stock and market information at Realpennies